Avid Bioservices Inc (CDMO)

[pphmtoolong]

Peregrine is moving forward. No easy trick considering the huge disappointment of the Sunrise trial.

Thanks to Avid, Peregrine is growing financially stronger every quarter. Still on track for profitability in 18 months.

While Bavi has not achieved the success we hoped for, it is still alive. Sadly, we won't know how alive until the new clinical trials get underway. Sadder still these trials are not moving quickly. On the bright side as they are not company sponsored trials they are cheap.

Beyond Bavi and Avid, there are a few other Peregrine efforts underway but not visible enough to warrant featuring in the CC.

As a big loser on the share price, I understand the non-stop negativity here. However, anyone who hangs around might be rewarded. Maybe not very likely, but definitely possible.

GLTA, Paul